During the final quarter of 2015, start-up companies raised a total of $2.41 billion, $156 million less than the previous quarter but a 65% increase from Q4 2014's total of $1.46 billion. Forty-five biopharma companies combined for $2.24 billion, about 50% resulting from Series As ($1.17 billion). Two medical device firms together raised $63.5 million in Series B financing, accounting for half of the total $126.6 million in device funding. Five in vitro diagnostics start-ups pulled in $45.2 million. (See Exhibit 1.)
To date, 2015 saw the most fundraising ($10.33 billion in all), and Q1 remains the highest quarterly total on record...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?
